[Common femoral artery bailout stenting with covered stent graft due to TAVR vascular complication: Clinical long term follow-up]

Ann Cardiol Angeiol (Paris). 2019 Nov;68(5):316-324. doi: 10.1016/j.ancard.2019.08.007. Epub 2019 Sep 27.
[Article in French]

Abstract

Background: Vascular complications are frequent in the context of transcatheter aortic valve replacement and may require the implantation of a covered stent graft in the common femforal artery. However, common femoral artery is considered to be at high risk of stent fracture or occlusion due to high mobility of the hip joint.

Patients and methods: We analyzed medical records of patients with transcatheter aortic valve replacement related vascular complications between 2015 and 2018, treated with commom femoral artery transluminal angioplasty or surgery. Vascular complications or suspect symptoms were followed up by phone calls.

Results: Among 552 patients, 43 patients were included. Twelve (11.6 %) were managed by prolonged balloon inflation, 5 (11.6 %) by first line surgery and 26 (60.4 %) by the implantation of a covered stent graft. Among the latter group, the covered stent graft was efficient in 24 patients (92.3 %). The median follow-up was 430 days [3-1499]. The first-line surgery group had a higher risk of red blood cell transfusion and all causes mortality. At follow-up, no patient had suspicious symptoms of vascular covered stent complication. Four patients (9.3 %) had US-doppler or CT vascular imaging at follow-up, showing no evidence of stent fracture or occlusion.

Conclusion: In our study, the implantation of a covered stent graft in the common femoral artery was an efficient and safe strategy for the management of transcatheter aortic valve replacement related vascular complications.

Keywords: Access site complication; Artère fémorale commune; Common femoral artery; Complication vasculaire; Covered stent graft; Fracture de stent; Remplacement valvulaire aortique percutané; Stent couvert; Stent fracture; TAVI; TAVR; Transcatheter aortic valve replacement.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Female
  • Femoral Artery / surgery*
  • Follow-Up Studies
  • Humans
  • Male
  • Postoperative Complications / surgery*
  • Prosthesis Design
  • Retrospective Studies
  • Stents*
  • Time Factors
  • Transcatheter Aortic Valve Replacement* / adverse effects
  • Vascular Diseases / etiology
  • Vascular Diseases / surgery*